A looser clothing fit
Many patients first notice change in how clothing fits rather than on the scale.
Compounded weight-management care
Weight loss, personalized to your body — down to the formula.
Compounded Tirzepatide/Glycine/B12
Tirzepatide works through both GIP and GLP-1 receptor pathways to support appetite regulation, satiety, and metabolic signaling. Graceland Wellness prescribes it, compounded with glycine and B12, only for eligible patients when a patient-specific treatment is clinically appropriate.
- Tirzepatide supports appetite, satiety, and metabolic signaling through GIP and GLP-1 receptor activity
- Typically used on a once-weekly subcutaneous schedule as prescribed
- Glycine and cyanocobalamin (B12) included as components of the compounded formulation
- Private telehealth evaluation, individualized dosing, and ongoing follow-up
1 / 3
Steady progress
Progress you can feel in your clothes.
A weekly, provider-guided routine built around your health history and response.
The image shown is for illustrative purposes only and does not represent the actual appearance of your specific compounded medication.
- Type
- GIP/GLP-1 injection
- Frequency
- Once weekly
- Formula
- Tirzepatide + Glycine + B12
- Status
- Not FDA-approved
- Access
- Prescription only
Weight-management support
Weight-management support, personalized for you
Your clinician and dispensing pharmacy determine the patient-specific concentration, dose, and administration instructions.
What is included
Whole-person metabolic support
Each component has a distinct role. The inclusion of glycine or B12 does not establish greater weight-loss effectiveness or fewer side effects.
Patient-specific prescribing comes first
This formulation is prescribed only after a clinician reviews your health history, goals, medications, contraindications, and available alternatives.
Tirzepatide acts on GIP and GLP-1 receptor pathways involved in appetite regulation, satiety, and glucose-dependent metabolic signaling.
Glycine and cyanocobalamin are included as components of the compounded formulation when clinically appropriate.
Individualized instructions come from your prescription label and clinician—not a universal online dose chart.
The specific compounded formulation has not been independently studied in clinical trials. No particular outcome is guaranteed.
Dosing precision
Measure the prescribed dose exactly
Concentration can vary between compounded products. FDA has reported dosing errors caused by confusion between milligrams, milliliters, and syringe “units.”
Before every injection
- Confirm the medication name, concentration, and prescribed dose.
- Use the syringe and markings specified by your pharmacy.
- Ask your Care Team to clarify any mismatch or uncertainty before injecting.
- Never convert between mg, mL, and units or adjust your own dose.
Injection guidance
A clear weekly routine
Your prescription label and clinician instructions always control your exact dose and administration.
Confirm medication and dose
Read the label and verify the prescribed amount before drawing medication into the syringe.
Measure exactly
Use only the supplied or recommended syringe. Do not estimate, convert, or change the prescribed dose.
Inject subcutaneously
Use the technique demonstrated by your Care Team and rotate among approved injection sites each week.
Medication, routine, and provider guidance
One weekly step inside a supported plan
Medication is one part of care. Your Care Team supports the routine around it.
Appropriate use
Prescribed for your specific clinical needs
Compounded treatment is considered only after a licensed provider reviews whether it is appropriate for you and discusses available FDA-approved alternatives.
Clinical review. Your provider evaluates your history, current medications, and contraindications.
Documented consent. You receive a clear explanation of the compounded product's regulatory status, risks, and alternatives.
Ongoing oversight. Follow-up supports tolerability, safe titration, and questions about administration.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or efficacy.
Common side effects
Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, indigestion, and fatigue may occur, especially during titration.
Serious risks
Risks include pancreatitis, gallbladder disease, kidney injury from dehydration, serious allergic reactions, severe gastrointestinal problems, low blood sugar with certain diabetes medicines, and complications related to diabetic retinopathy.
Tell every treating clinician
Tirzepatide delays stomach emptying and may affect procedures involving anesthesia or deep sedation. Share your medication list before any procedure.
Pregnancy
Weight-loss treatment should not be used during pregnancy. Tell your provider if you are pregnant, planning pregnancy, or breastfeeding.
Habits that last
Build a plan that supports the way you want to live
Medication can support appetite regulation, while practical nutrition, movement, sleep, and stress routines help make your plan sustainable. Your Care Team helps you focus on realistic changes—not perfection.
What patients notice
Small, steady changes
Individual outcomes vary. No particular result is guaranteed.
Confident in the mirror
Consistent routines and follow-up support progress you can maintain.
Questions, answered
Compounded Tirzepatide/Glycine/B12, explained
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.
No. Compounded tirzepatide is a different product from FDA-approved tirzepatide products. It may differ in concentration, container, inactive ingredients, and administration. Follow only the prescription label and instructions provided for your compounded medication.
No. This page does not claim that glycine or cyanocobalamin (B12) independently improve effectiveness or reduce tirzepatide side effects. They are included as components of this patient-specific compounded formulation when your prescriber determines it is appropriate.
Compounded tirzepatide products can come in different concentrations and containers. FDA has reported dosing errors involving confusion between milligrams, milliliters, and syringe “units.” Confirm the concentration, prescribed dose, and syringe markings before every injection, and contact your Care Team if anything is unclear.
No. Do not adjust your own dose or advance your schedule. Your clinician individualizes titration based on your prescription, response, side effects, and medical history.
Use and store the medication exactly as your pharmacy label directs. Before each dose, confirm the medication and concentration, measure the exact prescribed amount, inject subcutaneously as instructed, and rotate injection sites.
No. Completing an assessment does not guarantee treatment. A licensed provider must determine that a patient-specific compounded prescription is clinically appropriate for you.
Personalized weight-management care
Find out whether this option is appropriate for you
Complete a private assessment for review by a licensed provider. A prescription is never guaranteed, and your clinician will discuss appropriate options based on your health history.
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment requires provider evaluation and a patient-specific prescription. Your prescription label and clinician instructions control your exact dose and administration.